mailed
on 31 Oct 2024
Last Applicant/ Owned by
FRIEDRICH-MIESCHER-STR. 15
T�BINGEN
DE
72076
Serial Number
97694840 filed on 28th Nov 2022
Registration Number
N/A
Correspondent Address
Jennifer Fraser
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules; pre-clinical and clinical testing of macromolecules Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic disease Read More
Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; Vaccination
N/A
N/A
Scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules; pre-clinical and clinical testing of macromolecules
N/A
N/A
Laboratory apparatus and instruments, namely, pre-packed columns for use in chemical synthesis; mobile laboratory robots with artificial intelligence for use in scientific, diagnostic and pharmaceutical research and for use in pharmaceutical production and laboratory automation; mobile device for the synthesis of macromolecules, namely, for therapeutic and preventive treatment of tumor diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; Mobile production station of biological macromolecules, namely, for therapeutic and preventive treatment of tumor diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; bioreactors for growing cells
N/A
N/A
Machines for use in chemical or biopharmaceutical industry, namely for the synthesis of macromolecules; Bioreactors for the synthesis of macromolecules; Filling machines, in particular for use for filling biopharmaceutical compositions into containers; Industrial robots
N/A
N/A
Chemical preparations for medical use, namely, biological macromolecules, namely, for therapeutic and preventive treatment of tumor diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; Pharmaceutical and veterinary preparations for medical and veterinary use; Pharmaceuticals and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for treatment or prevention of infectious diseases, allergies, autoimmune disorders and tumor diseases, for treatment of metabolic disorders and for treatment of inherited genetic diseases or for protein or enzyme replacement therapy; Gene therapeutic preparations; Dietetic substances adapted for medical use, in particular substances for food supplements; Vaccines
N/A
N/A
Chemicals and biomolecules, namely, biological macromolecules, for industrial or scientific purposes other than for medical or veterinary purposes; Reagents for research purposes; Reagents for use in scientific apparatus for chemical or biological analysis and/or synthesis
N/A
N/A
Custom synthesis of chemical compounds, namely, biological macromolecules, to the order and specifications of others
N/A
N/A
No 97694840
No Service Mark
No 067249-00061
Yes
Yes
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
04th Dec 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
31st Oct 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
31st Oct 2024 | INQUIRY TO SUSPENSION E-MAILED |
31st Oct 2024 | SUSPENSION INQUIRY WRITTEN |
29th Oct 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
12th Dec 2023 | LETTER OF SUSPENSION E-MAILED |
12th Dec 2023 | SUSPENSION LETTER WRITTEN |
12th Dec 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
12th Dec 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
11th Dec 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |